Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
Kidney Int ; 71(12): 1262-70, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17410101

ABSTRACT

Hyperphosphatemia is a driving force in the pathogenesis of vascular calcification (VC) and secondary hyperparathyroidism associated with renal failure. To test for the possible contribution of parathyroid hormone (PTH) to cardiovascular calcification, we removed the parathyroid glands from rats but infused synthetic hormone at a supraphysiologic rate. All rats were pair-fed low, normal, or high phosphorus diets and subjected to a sham or 5/6 nephrectomy (remnant kidney). Control rats were given a normal diet and underwent both sham parathyroidectomy and 5/6 nephrectomy. Heart weight/body weight ratios and serum creatinine levels were higher in remnant kidney rats than in the sham-operated rats. Remnant kidney rats on the high phosphorus diet and PTH replacement developed hyperphosphatemia and hypocalcemia along with low bone trabecular volume. Remnant kidney rats on the low phosphorus diet or intact kidney rats on a normal phosphorus diet, each with hormone replacement, developed hypercalcemia. All rats on PTH replacement developed intense aortic medial calcification, and some animals presented coronary calcification. We suggest that high PTH levels induce high bone turnover and medial calcification resembling Mömckeberg's sclerosis independent of uremia. This model may be useful in defining mechanisms underlying VC.


Subject(s)
Calcinosis/complications , Cardiovascular Diseases/complications , Disease Models, Animal , Parathyroid Hormone/physiology , Rats , Renal Insufficiency/etiology , Animals , Aorta/pathology , Body Weight/drug effects , Bone Remodeling , Calcinosis/metabolism , Calcinosis/pathology , Cardiovascular Diseases/metabolism , Cardiovascular Diseases/pathology , Coronary Vessels/pathology , Eating/drug effects , Hypercalcemia/etiology , Male , Parathyroid Hormone/pharmacology , Plethysmography , Rats, Wistar
2.
Braz J Med Biol Res ; 27(3): 655-61, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8081290

ABSTRACT

Administration of methylmalonic acid in rats has been used as a model for methylmalonicacidemia in humans. Nestling Wistar rats of both sexes received 5 injections daily at 3-h intervals (starting at 7:30 a.m.) of saline or methylmalonic acid (MMA, 10 mg/ml) in a volume of 9 microliters/g body weight per injection subcutaneously in the lumbar region from the 5th to the 9th day of life and 11 microliters/g from day 10 to 14. Growth and neuromotor development were assessed by monitoring the following parameters daily in 54 rats: body weight, ear unfolding, incisor eruption, eye opening, righting, palmar grasp, negative geotaxis, cliff avoidance, free-fall righting and startle reflex. The only statistically significant effects of MMA administration were on the day of appearance of the free-fall righting reflex: MMA, 12.44 +/- 1.55 vs 11.0 +/- 0.39 days for saline control (P < 0.05, by two-way ANOVA) and a significant decrease in weight (P < 0.05, by ANOVA with repeated measures). The results suggest that chronic MMA administration to rats has a selective effect on neuromotor development.


Subject(s)
Behavior, Animal/drug effects , Methylmalonic Acid/pharmacology , Animals , Body Weight/drug effects , Female , Growth/drug effects , Male , Methylmalonic Acid/administration & dosage , Motor Activity/drug effects , Rats , Rats, Wistar , Reflex/drug effects , Time Factors
3.
Braz. j. med. biol. res ; 27(3): 655-61, Mar. 1994. tab, graf
Article in English | LILACS | ID: lil-148938

ABSTRACT

Administration of methylmalonic acid in rats has been used as a model for methylmalonicacidemia in humans. Nestling Wistar rats of both sexes received 5 injections daily at 3-h intervals (starting at 7:30 a.m.) of saline or methylmalonic acid (MMA, 10 mg/ml) in a volume of 9 microliters/g body weight per injection subcutaneously in the lumbar region from the 5th to the 9th day of life and 11 microliters/g from day 10 to 14. Growth and neuromotor development were assessed by monitoring the following parameters daily in 54 rats: body weight, ear unfolding, incisor eruption, eye opening, righting, palmar grasp, negative geotaxis, cliff avoidance, free-fall righting and startle reflex. The only statistically significant effects of MMA administration were on the day of appearance of the free-fall righting reflex: MMA, 12.44 +/- 1.55 vs 11.0 +/- 0.39 days for saline control (P < 0.05, by two-way ANOVA) and a significant decrease in weight (P < 0.05, by ANOVA with repeated measures). The results suggest that chronic MMA administration to rats has a selective effect on neuromotor development


Subject(s)
Animals , Male , Female , Rats , Methylmalonic Acid/pharmacology , Behavior, Animal/drug effects , Methylmalonic Acid/administration & dosage , Body Weight/drug effects , Growth/drug effects , Motor Activity/drug effects , Rats, Wistar , Reflex/drug effects , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...